Analgesic Use and Ovarian Cancer Risk: An Analysis in the Ovarian Cancer Cohort Consortium
Year: 2018
Type: article
Abstract: (Abstracted from J Natl Cancer Inst 2018; doi: 10.1093/jnci/djy100) The most fatal gynecologic cancer is ovarian cancer. This is largely due to its delayed symptom presentation and lack of early detection strategies.
Authors: Britton Trabert, Elizabeth M. Poole, Emily White, Kala Visvanathan, Hans-Olov Adami, Garnet L. Anderson, Theodore M. Brasky, Louise A. Brinton, Renee T. Fortner, Mia Gaudet, Patricia Hartge, Judith Hoffman-Bolton, Michael Jones, James V. Lacey, Susanna C. Larsson, Gerardo G. Mackenzie, Leo J. Schouten, Dale P. Sandler, Katie O'Brien, Alpa V. Patel, Ulrike Peters, Anna Prizment, Kim Robien, Wendy V. Setiawan, Anthony Swerdlow, Piet A. van den Brandt, Elisabete Weiderpass, Lynne R. Wilkens, Alicja Wolk, Nicolas Wentzensen, Shelley S. Tworoger
Institutions: University of Southern California, Brigham and Women's Hospital, American Cancer Society, National Institutes of Health, City Of Hope National Medical Center, University of Minnesota, Harvard University, Institute of Cancer Research, Johns Hopkins University, German Cancer Research Center, University of Oslo, George Washington University, Karolinska Institutet, Moffitt Cancer Center, Maastricht University, Fred Hutch Cancer Center, National Institute of Environmental Health Sciences, City of Hope, Cancer Registry of Norway, National Cancer Institute, Folkhälsans Forskningscentrum, University of Hawaii Cancer Center, Masonic Cancer Center, Division of Cancer Epidemiology and Genetics, The Ohio State University, UiT The Arctic University of Norway, University of California, Davis
Language: English
Topic: Cancer Risks and Factors
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: green
OpenAlex ID: W2898524439